SCHEMBL12470

SCHEMBL12470

c1cc2cc[nH]c2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29465576 1.00 — —
SCHEMBL706764 1.00 MAPT (0.50) —
SCHEMBL27728878 0.98 — —
Hydrochloric Acid SCHEMBL2978417 0.98 MAPT (0.49) —
SCHEMBL7491548 0.98 MAPT (0.49) —
Hydrochloric Acid SCHEMBL5532283 0.98 MAPT (0.49) —
Bromide SCHEMBL1242434 0.98 MAPT (0.49) —
SCHEMBL17372872 0.92 MAPT (0.45) —
Formic Acid SCHEMBL23291890 0.88 CCNC (0.44) —
Phosphoric Acid SCHEMBL3828696 0.88 MAPT (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5461 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4482583-B1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2026-04-01 — — EP claimed
US-12528822-B2 Cycloalkane-1,3-diamine derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2026-01-20 — — US claimed
EP-4678634-A1 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF Haihe Biopharma Co., Ltd. (CN) 2026-01-14 — — EP claimed
US-20250388599-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2025-12-25 — — US claimed
US-20250387504-A1 ANTIBODY-DRUG CONJUGATES OF ANTINEOPLASTIC COMPOUNDS AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2025-12-25 — — US claimed
US-20250179066-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2025-06-05 — — US claimed
WO-2025111431-A1 ANTI-CD7 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF LES LABORATOIRES SERVIER (FR) 2025-05-30 — — WO claimed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 — — WO claimed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 — — CN claimed
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 — — WO claimed
WO-2001005758-A2 INDOLES AND INDAZOLES FOR THE TREATMENT OF MIGRAINE NPS ALLELIX CORP. (CA) 2001-01-25 — — WO claimed
WO-2000075139-A2 BENZOTHIAZINONE AND BENZOXAZINONE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2000-12-14 — — WO claimed
WO-2000037074-A1 MUTILIN 14-ESTER DERIVATIVES HAVING ANTIBACTERIAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 2000-06-29 — — WO claimed
US-5484793-A NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1996-01-16 — — US claimed
US-5468757-A FOR TREATING STROKE OR MYOCARDIAL INFARCTION IN HUMANS ELI LILLY AND COMPANY (US) 1995-11-21 — — US claimed
EP-0668279-A2 6-Azaindole thromboxane synthase inhibitors ELI LILLY AND COMPANY (US) 1995-08-23 — — EP claimed
EP-0586526-A1 AZA-6-INDOLE-DERIVED COMPOUNDS AS BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1994-03-16 — — EP claimed
WO-1992021680-A1 AZA-6-INDOLE-DERIVED COMPOUNDS AS BENZODIAZEPINE RECEPTOR LIGANDS AND DRUGS CONTAINING SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1992-12-10 — — WO claimed
EP-0187631-B1 PROCESS FOR THE PREPARATION OF PYRROLOPYRIDINE DERIVATIVES, AND DERIVATIVES SO OBTAINED SANOFI (FR) 1990-09-05 — — EP claimed
EP-0186431-B1 ANTI-HYPERTENSIVE OCTAHYDRO-6-AZAINDOLE DIPEPTIDE DERIVATIVES Pfizer Limited (GB) 1988-02-03 — — EP claimed
Send feedback